The immunology of multiple sclerosis by Attfield, KE, Jensen, LT, Kaufmann, M, Friese, MA, Fugger, L

Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis by Kaufmann, M, Evans, H, Schaupp, A-L, Engler, JB, Kaur, G, Willing, A, Kursawe, N, Schubert, C, Attfield, KE, Fugger, L, Friese, MA

A novel neurodegenerative spectrum disorder in patients with MLKL deficiency by Faergeman, SL, Evans, H, Attfield, KE, Desel, C, Kuttikkatte, SB, Sommerlund, M, Jensen, LT, Frokiaer, J, Friese, MA, Matthews, PM, Luchtenborg, C, Brügger, B, Oturai, AB, Dendrou, CA, Fugger, L

Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade by Kaur, G, Porter, CBM, Ashenberg, O, Lee, J, Riesenfeld, SJ, Hofree, M, Aggelakopoulou, M, Subramanian, A, Kuttikkatte, SB, Attfield, KE, Desel, CAE, Davies, JL, Evans, HG, Avraham-Davidi, I, Nguyen, LT, Dionne, DA, Neumann, AE, Jensen, LT, Barber, TR, Soilleux, E, Carrington, M, McVean, G, Rozenblatt-Rosen, O, Regev, A, Fugger, L

Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases by Lippert, AH, Paluch, C, Gaglioni, M, Vuong, MT, McColl, J, Jenkins, E, Fellermeyer, M, Clarke, J, Sharma, S, Moreira da Silva, S, Akkaya, B, Anzilotti, C, Morgan, SH, Jessup, CF, Koerbel, M, Gileadi, U, Leitner, J, Knox, R, Chirifu, M, Huo, J, Yu, S, Ashman, N, Lui, Y, Wilkinson, I, Attfield, KE, Fugger, L, Robertson, NJ, Lynch, CJ, Murray, L, Steinberger, P, Santos, AM, Lee, SF, Cornall, RJ, Klenerman, D, Davis, SJ